November 6, 2017 — The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...
TCT
This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.
November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...
November 6, 2017 — Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...
The optimal delivery of cardiac care is evolving rapidly. A growing number of patients combined with innovative new ...
November 3, 2017 — Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...
November 3, 2017 — Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini ...
November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...
November 2, 2017 — Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...
November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...
November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...
November 1, 2017 — Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary ...
November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter ...
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strategy ...
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the ...
October 31, 2017 — Edwards Lifesciences Corp. announced new data demonstrating substantial economic advantages of the ...
November 06, 2017